A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus
Clinical Rheumatology · 2024
DOI: 10.1007/s10067-024-06917-4 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Mengjie Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The First People's Hospital of Wenling, Zhejiang, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Lupus Erythematosus, Systemic, Latent Infection. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Wenling Social Development Science and Technology Program.
Abstract (Originalsprache)
OBJECTIVES: Systemic lupus erythematosus (SLE) and the Epstein-Barr virus (EBV) are very closely related. This study estimated the impact of EBV infection status on clinical manifestations and disease remission in patients with SLE. METHOD: A retrospective study was performed using electronic health records of patients with SLE. The SLE disease activity index (SLEDAI-2 K) was used to assess disease activity. VCAIgM or EAIgM positive or EBVDNA copies ≥ 50 IU/mL were defined as lytic infection group, EBNA-IgG or VCAIgG-positive and who were negative for both VCAIgM and EAIgM with EBVDNA copies < 50 IU/mL were defined as the latent infection group. The endpoint (disease remission) was defined as a decrease in SLEDAI-2 K score of ≥ 1 grade or ≥ 4 points from baseline. The association between EBV infection status and disease remission was assessed using propensity score weighting and multivariable Cox regression models. RESULTS: There were 75 patients with SLE in the EBV lytic infection group and 142 patients in the latent infection group. The SLEDAI-2 K score was higher in the lytic infection group (10.00 (6.25, 16.00) vs. 8.00 (5.00, 10.00), Z = 3.96, P < 0.001). There was a significant difference in the effect of EBV lytic infection on disease remission compared to latent infection (HR 0.30, 95% CI 0.19-0.49, P < 0.001). CONCLUSIONS: Patients with SLE with lytic EBV infection have higher disease activity and take longer to achieve remission. Our study furthers our understanding of the relationship between SLE and EBV infection and may inform better treatment practices in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, The First People's Hospital of Wenling, Zhejiang, China.
- Department of Rheumatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Rheumatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. grassandsun@126.com.
Förderung
- Wenling Social Development Science and Technology Program
Zitieren
APA
Chen, M., Tu, J., Huang, M., Cheng, Y., & Sun, L. (2024). A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-06917-4
Vancouver
Chen M, Tu J, Huang M, Cheng Y, Sun L. A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-06917-4
BibTeX
@article{Chen2024,
author = {Chen, Mengjie and Tu, Jianxin and Huang, Mingyu and Cheng, Yongjun and Sun, Li},
title = {A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus},
journal = {Clinical Rheumatology},
year = {2024},
doi = {10.1007/s10067-024-06917-4}
}
EUVIMED